Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Main Authors: Kaufman, Howard L, Aung, Sandra, Morse, Michael, Wong, Michael, Lowder, James, Daniels, Gregory, McDermott, David
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Poster Presentation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4288765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-2-S3-P88
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares